StockData
SNDL Inc. logo

SNDL Inc. (SNDL) stock

SNDLNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2026, year ended Dec 31, 2025Last filing: 40-F on Mar 12, 2026Score 5/30
$1.34+0.00 (0.00%)

Close on Nov 17, 2026Market cap $352.90MP/E –Yield –

SNDL r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2026 it was C$489.00K, up 41.3% from the year before. The highest annual figure on record is C$2.45M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Dec 31, 2025C$489.00K+41.3%
FY2025Dec 31, 2024C$346.00K+6.8%
FY2024Dec 31, 2023C$324.00K-86.8%
FY2023Dec 31, 2022C$2.45M+0.1%
FY2022Dec 31, 2021C$2.45M+401.2%
FY2021Dec 31, 2020C$488.00K-79.8%
FY2020Dec 31, 2019C$2.41M+483.5%
FY2018Feb 28, 2018C$413.00K–

More SNDL figures

See a number that looks wrong?